APG-2305

N/A

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameAPG-2305
Drug Alias NameAPG2305
ClassificationSmall molecules > Synthetic peptide
Mechanisms of ActionInterleukin 23 Receptor inhibitors
TargetsInterleukin 23 Receptor
Therapy Area/IndicationsAutoimmune DiseasesArthritis, Psoriatic
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesAllostera Pharma
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAllostera Pharma
Active IndicationsN/A
Inactive IndicationsAutoimmune DiseasesArthritis, Psoriatic

Other Information

ATC CodeN/A
Related LinksN/A